Development of a NK cell expansion protocol for use in assessments of NK-targeting therapeutics.
The Neonatal Fc Receptor (FcRn) shows promising therapeutic potential in autoimmunity and other conditions.
Partnership with lab-on-a-chip startup will help simulate complex disease states and accelerate drug discovery.
Antibody Analytics' in-house SPR experts discuss our custom SPR assay services and answer FAQs!
The partnership promotes collaboration between universities and industries across life science.
Our CSO Dr Agapitos Patakas presents our in vitro T cell exhaustion model.
Research often targets the capabilities of T cells, but B cells also hold therapeutic potential.
We’re excited to work with an organisation that empowers Black ethnic minority workers.
Our Senior Study Scientist Dr Luke Muir talks B cells.
We are delighted to share that Antibody Analytics is shortlisted for Scotland’s Life Sciences Business Leadership Award 2024!
This week marks National Apprenticeship Week!
The risk of a brain drain from Scotland is ever present...